Cor Vasa 2022, 64(4):403-410 | DOI: 10.33678/cor.2022.028

(Permanent pacemaker implantation in patients undergoing TAVR - single center study between years 2009 and 2021)

Adéla Drozdová, Otakar Jiravský, Jakub Balušík, Jan Chovančík, Libor Škňouřil
Komplexní kardiovaskulární centrum, Nemocnice Agel Třinec-Podlesí, Třinec

Introduction: Transcatheter aortic valve replacement (TAVR) is becoming more prevalent option of aortic valve replacement, predominantly amongst patients with a higher surgical risk. Despite a rapid development of TAVR prostheses, incidence of conduction abnormalities requiring cardiac pacing as a result of TAVR is not significantly decreasing. There are numerous risk factors which can help to predict the risk for cardiac pacing after TAVR.

Keywords: BSA, Men, Pacing, RBBB, TAVR

Received: January 21, 2022; Revised: March 1, 2022; Accepted: March 18, 2022; Published: September 1, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drozdová A, Jiravský O, Balušík J, Chovančík J, Škňouřil L. (Permanent pacemaker implantation in patients undergoing TAVR - single center study between years 2009 and 2021). Cor Vasa. 2022;64(4):403-410. doi: 10.33678/cor.2022.028.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Meredith IT, Worthley SG, Whitbourn RJ, et al. Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study. EuroIntervention 2014;9:1264-70. Go to original source... Go to PubMed...
    2. Binder RK, Rodés-Cabau J, Wood DA, et al. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon- -expandable transcatheter heart valve. JACC Cardiovasc Interv 2013;6:293-300.3 Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016;374:1609-1620. Go to original source... Go to PubMed...
    3. 4 Still S, Szerlip M, Mack M. TAVR Vs. SAVR in Intermediate-Risk Patients: What Influences Our Choice of Therapy. Curr Cardiol Rep 2018;20:82. Go to PubMed...
    4. Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2017;376:1321-1331. Go to original source... Go to PubMed...
    5. Mc Morrow R, Kriza C, Urbán P, et al. Assessing the safety and efficacy of TAVR compared to SAVR in low-to-intermediate surgical risk patients with aortic valve stenosis: An overview of reviews. Int J Cardiol 2020;314:43-53. Go to original source... Go to PubMed...
    6. Nazif TM, Dizon JM, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. JACC Cardiovasc Interv 2015;8(1 Pt A):60-69. Go to original source... Go to PubMed...
    7. Ledwoch J, Franke J, Gerckens U, et al. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the German transcatheter aortic valve interventions registry. Catheter Cardiovasc Interv 2013;82:E569-E577. Go to original source... Go to PubMed...
    8. van Rosendael PJ, Delgado V, Bax JJ. Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review. Eur Heart J 2018;39:2003-2013. Go to original source... Go to PubMed...
    9. Meduri CU, Kereiakes DJ, Rajagopal V, et al. Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial. J Am Heart Assoc 2019;8:e012594. Go to original source... Go to PubMed...
    10. Chow SCY, Wong RHL, Cheung GSH, et al. Short term clinical outcomes and analysis of risk factors for pacemaker implantation: a single center experience of self-expandable TAVI valves. J Cardiothorac Surg 2020;15:200. Go to original source... Go to PubMed...
    11. Costa G, Zappulla P, Barbanti M, et al. Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes. EuroIntervention 2019;15:875-883. Go to original source... Go to PubMed...
    12. Toggweiler S, Kobza R. Pacemaker implantation after transcatheter aortic valve: why is this still happening? J Thorac Dis 2018;10(Suppl 30):S3614-S369. Go to original source... Go to PubMed...
    13. Auffret V, Webb JG, Eltchaninoff H, et al. Clinical Impact of Baseline Right Bundle Branch Block in Patients Undergoing Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv 2017;10:1564-1574. Go to original source... Go to PubMed...
    14. Mahajan S, Gupta R, Malik AH, et al. Predictors of permanent pacemaker insertion after TAVR: A systematic review and updated meta-analysis. J Cardiovasc Electrophysiol 2021;32:1411-1420. Go to original source... Go to PubMed...
    15. Veulemans V, Frank D, Seoudy H, et al. New insights on potential permanent pacemaker predictors in TAVR using the largest self-expandable device. Cardiovasc Diagn Ther 2020;10:1816-1826. Go to original source... Go to PubMed...
    16. Mazzella AJ, Sanders M, Yang H, et al. Predicting need for pacemaker implantation early and late after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2021;97:E588-E596. Go to original source... Go to PubMed...
    17. Du F, Zhu Q, Jiang J, et al. Incidence and Predictors of Permanent Pacemaker Implantation in Patients Who Underwent Transcatheter Aortic Valve Replacement: Observation of a Chinese Popuation. Cardiology 2020;145: 27-34. Go to original source... Go to PubMed...
    18. Maan A, Refaat MM, Heist EK, et al. Incidence and Predictors of Pacemaker Implantationin Patients Undergoing Transcatheter Aortic Valve Replacement. Pacing Clin Electrophysiol 2015;3:878-886. Go to original source... Go to PubMed...
    19. Mauri V, Deuschl F, Frohn T, et al. Predictors of paravalvular regurgitation and permanent pacemaker implantation after TAVR with a next-generation self-expanding device. Clin Res Cardiol 2018;107:688-697. Go to original source... Go to PubMed...
    20. Toggweiler S, Humphries KH, Lee M, et al. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol 2013;61:413-419. Go to original source... Go to PubMed...
    21. Buellesfeld L, Stortecky S, Heg D, et al. Impact of Permanent Pacemaker Implantation on Clinical Outcome Among Patients Undergoing Transcatheter Aortic Valve Implantation. J Am Coll Cardiol 2012;60:493-501. Go to original source... Go to PubMed...
    22. Engborg J, Riechel-Sarup C, Gerke O, et al. Effect of permanent pacemaker on mortality after transcatheter aortic valve replacement. Scand Cardiovasc 2017;51:40-46. Go to original source... Go to PubMed...
    23. Regueiro A, Abdul-Jawad Altisent O, Del Trigo M, et al. Impact of New-Onset Left Bundle Branch Block and Periprocedural Permanent Pacemaker Implantation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Circ Cardiovasc Interv 2016;9:e003635. Go to original source... Go to PubMed...
    24. Brennan P. 56 Predictors and impact of pacemaker implantation following TAVI; the northern irish dataset. Heart 2019;105(Suppl 7):A44-A45. Go to original source...
    25. Zhang Z, Rautaharju PM, Soliman EZ, et al. Mortality risk associated with bundle branch blocks and related
    26. Fujita B, Schmidt T, Bleiziffer S, et al. Impact of new pacemaker implantation following surgical and transcatheter aortic valve replacement on 1-year outcome. Eur J Cardio-Thorac Surg 2020;57:151-159. Go to original source... Go to PubMed...
    27. Solomonica A, Choudhury T, Bagur R. The mechanically expandable LOTUS Valve and LOTUS Edge transcatheter aortic valve systems. Expert Rev Med Devices 2018;15:763-769. Go to original source... Go to PubMed...
    28. Rashid HNZ, Gooley R, McCormick L, et al. Safety and efficacy of valve repositioning during transcatheter aortic valve replacement with the Lotus Valve System. J Cardiol 2017;70:55-61. Go to original source... Go to PubMed...
    29. Rampat R, Khawaja MZ, Hilling-Smith R, et al. Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience. JACC Cardiovasc Interv 2017;10:1247-1253. Go to original source... Go to PubMed...
    30. Khawaja MZ, Rajani R, Cook A, et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation 2011;123:951-960. Go to original source... Go to PubMed...
    31. Levack MM, Kapadia SR, Soltesz EG, et al. Prevalence of and Risk Factors for Permanent Pacemaker Implantation After Aortic Valve Replacement. Ann Thorac Surg 2019;108:700-707. Go to original source... Go to PubMed...
    32. Sündermann SH, Holzhey D, Bleiziffer S, et al. Medtronic EngagerTM bioprosthesis for transapical transcatheter aortic valve implantation. EuroIntervention 2013;9(Suppl):S97-S100. Go to original source... Go to PubMed...
    33. Lange P, Greif M, Vogel A, et al. Reduction of pacemaker implantation rates after CoreValve® implantation by moderate predilatation. EuroIntervention 2014;9:1151-1157. Go to original source... Go to PubMed...
    34. Tichelbäcker T, Bergau L, Puls M, et al. Insights into permanent pacemaker implantation following TAVR in a real-world cohort. PloS One 2018;13:e0204503. Go to original source... Go to PubMed...
    35. Amat-Santos IJ, Dahou A, Webb J, et al. Comparison of hemodynamic performance of the balloon-expandable SAPIEN 3 versus SAPIEN XT transcatheter valve. Am J Cardiol 2014;114:1075-1082. Go to original source... Go to PubMed...
    36. Nombela-Franco L, Rodés-Cabau J, DeLarochellière R, et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon- -expandable valve. JACC Cardiovasc Interv 2012;5:499-512. Go to original source... Go to PubMed...
    37. Ahmad M, Patel JN, Loc BL, et al. Association Between Body Mass Index and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement (TAVR) with Edwards SAPIENTM 3 TAVR Valves: A Single-Center Experience. Cureus 2019;11:e5142. Go to original source... Go to PubMed...
    38. Alventosa-Zaidin M, Guix Font L, Benitez Camps M, et al. Right bundle branch block: Prevalence, incidence, and cardiovascular morbidity and mortality in the general population. Eur J Gen Pract 2019;25:109-115. Go to original source... Go to PubMed...
    39. Ikeda T. Right Bundle Branch Block: Current Considerations. Curr Cardiol Rev 2021;17:24-30. Go to original source... Go to PubMed...
    40. Bussink BE, Holst AG, Jespersen L, et al. Right bundle branch block: prevalence, risk factors, and outcome in the general population: results from the Copenhagen City Heart Study. Eur Heart J 2013;34:138-146. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes